Bengaluru, July 29 -- shares of a company engaged in the research, manufacturing & marketing of generic pharmaceutical formulations are in focus on the stock exchanges, after an asset management company bought stake in the company worth more than Rs. 167 crores.

At 11:05 a.m., the shares of Marksans Pharma Limited were trading in the red at Rs. 225.4 on BSE, down by around 0.5 percent, as against its previous closing price of Rs. 226.45, with a market cap of Rs. 10,214.3 crores. The stock has delivered positive returns of more than 11 percent in the last one year, but has fallen by nearly 14 percent in the last one month.

What's the News

According to the latest bulk deal data, an asset management company (AMC), Unifi Capital Private Li...